Sebacia is the first acne treatment that targets oil-producing glands to clear skin from the inside out.
It's a revolutionary, FDA-cleared treatment that works in three visits to your dermatologist with no downtime.
It's a revolutionary, FDA-cleared treatment that works in three visits to your dermatologist with no downtime.
Location: United States, Georgia, Duluth
Employees: 11-50
Total raised: $68M
Founded date: 2010
Investors 2
| Date | Name | Website |
| - | Domain Ass... | domainvc.c... |
| - | Hercules C... | htgc.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 25.07.2017 | Series D | $36M | Domain Ass... |
| 28.08.2015 | - | $10M | - |
| 25.06.2015 | Series C | $22M | - |
Mentions in press and media 12
| Date | Title | Description |
| 26.07.2017 | Term Sheet — Wednesday, July 26 | MORE CRYPTO Good morning. It’s Jen Wieczner taking over your Term Sheet today while Erin is away. Please send me your feedback at jen.wieczner@fortune.com and/or follow and DM me on Twitter: @jenwieczner. Paid Content What you need to know ... |
| 25.07.2017 | Sebacia grabs $36M to push gold microparticle acne treatment through FDA | |
| 25.07.2017 | Sebacia Raises $36M in Equity and Debt Financing | Sebacia, Inc., a Duluth, Ga.-based clinical and commercial stage dermatology and aesthetics company, completed a $20m Series D financing and a $16m debt facility. Backers included existing investors Versant Ventures, Domain Associates, Accu... |
| 25.07.2017 | Sebacia Announces $20M Series D Round | DULUTH, GA, Sebacia, a privately held, clinical and commercial stage dermatology and aesthetics company, today announced that the company has completed a $20 million Series D financing. >> Click here for more funding data on Sebaci... |
| 25.07.2017 | Sebacia Raises $20M Series D | Sebacia, Inc., a privately held, clinical and commercial stage dermatology and aesthetics company, today announced that the company has completed a $20 million Series D financing led by existing investors Versant Ventures, Domain Associates... |
| 25.07.2017 | Partners Healthcare Leads $20M Series D for Sebacia | Sebacia, Inc., a privately held, clinical and commercial stage dermatology and aesthetics company, today announced that the company has completed a $20 million Series D financing led by existing investors Versant Ventures, Domain Associates... |
| 25.07.2017 | Domain Associates Leads $20M Series D for Sebacia | Sebacia, Inc., a privately held, clinical and commercial stage dermatology and aesthetics company, today announced that the company has completed a $20 million Series D financing led by existing investors Versant Ventures, Domain Associates... |
| 28.08.2015 | Sebacia Receives $10M Credit Facility | Sebacia, Inc., a Duluth, Georgia-based clinical-stage medical device company dedicated to the treatment of dermatological conditions, received a $10m credit facility. Square 1 Bank provided the debt financing. The company intends to use the... |
| 26.06.2015 | Sebacia Completes $22M Series C Financing | Sebacia, Inc., a Duluth, GA-based company dedicated to delivering dermatology treatments, completed a $22m Series C financing. The financing includes $12m in equity from existing investors, Accuitive Medical Ventures, Domain Associates, Ver... |
| 25.06.2015 | A laser phototherapy cream that kills acne: Sebacia raises $22M | Sebacia expects a CE mark by the fourth quarter of this year; it’s projecting FDA approval by the second half of 2016. The funding will also cover a soft launch in Europe and later the U.S., CEO Anthony Lando said in a phone interview. Hair... |
Show more